Therefore, we may increase the level of ADNP and GDF11 m6A methylation modification in DM-BMSCs and, subsequently, restoring the impaired BMSC function in T2DM patients, then influence the implant success rate of patients with T2DM. This evidence concerns the gene GDF11 and type 2 diabetes mellitus.